Springer Nature AG & Co. KGaA (SPG.F)
Berlin, DE
Springer Nature AG & Co. KGaA primarily operates within the publishing sector. Its business scope also encompasses the creation, procurement, and promotion of information systems and complementary products. Additionally, the firm is involved in trading licenses and other intellectual property rights related to media and information systems. The company's principal office is located in Berlin, Germany.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.47% | -3.60% | +16.05% | +26.89% | -5.19% | +1.82% | +9.60% | -10.67% | -10.67% | -10.67% | -10.67% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 4 | 0 |
| Buy | 4 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Publishing: +0.8%+4.3% ★ Q4'25: +5.3% (vs Q4'23)
-
EPS growth Publishing: +9.6%+426.5% ★ Q4'25: +618.2% (vs Q4'23)
-
FCF margin FCF growth · Publishing: +28.6%+23.7% ★ Q4'25: +18.8% (vs Q4'23)
-
EBIT margin Publishing: +12.9%+23.3% ★ Q4'25: +10.6% (vs Q4'23)
-
ROIC Publishing: +7.5%+12.3% ★ Q4'25: +12.8% (vs Q4'23)
-
Share dilution Publishing: +0.0%-0.1% ★ Q4'25: -0.1% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Publishing: -0.41×2.11× Q4'25: 1.66× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 7 Rev. Ana. 8 EPS Ana. |
Dec 2027 7 Rev. Ana. 8 EPS Ana. |
Dec 2028 4 Rev. Ana. 7 EPS Ana. |
|---|---|---|---|---|---|
| Revenue |
1.85B
est: 1.84B (+0.2%)
|
1.93B
est: 1.92B (+0.3%)
|
1.98B
1.95B – 1.99B
+3.0% YoY
|
2.06B
2.03B – 2.08B
+4.4% YoY
|
2.16B
2.12B – 2.18B
+4.6% YoY
|
| EBITDA |
625.10M
est: 696.56M (-10.3%)
|
714.10M
est: 725.22M (-1.5%)
|
747.09M
736.86M – 751.43M
+3.0% YoY
|
779.82M
765.84M – 786.79M
+4.4% YoY
|
815.44M
802.51M – 821.48M
+4.6% YoY
|
| EBIT |
345.00M
est: 413.35M (-16.5%)
|
449.20M
est: 430.36M (+4.4%)
|
443.34M
437.26M – 445.91M
+3.0% YoY
|
462.76M
454.46M – 466.89M
+4.4% YoY
|
483.90M
476.22M – 487.48M
+4.6% YoY
|
| Net Income |
68.30M
est: 236.21M (-71.1%)
|
356.00M
est: 337.82M (+5.4%)
|
329.02M
317.29M – 349.22M
-2.6% YoY
|
356.26M
344.00M – 381.78M
+8.3% YoY
|
381.37M
373.51M – 385.04M
+7.0% YoY
|
| SGA |
227.00M
est: 401.99M (-43.5%)
|
694.00M
est: 418.53M (+65.8%)
|
431.15M
425.25M – 433.66M
+3.0% YoY
|
450.04M
441.97M – 454.07M
+4.4% YoY
|
470.60M
463.14M – 474.09M
+4.6% YoY
|
| EPS |
0.34
est: 1.19 (-71.4%)
|
1.79
est: 1.70 (+5.3%)
|
1.66
1.60 – 1.76
-2.6% YoY
|
1.79
1.73 – 1.92
+8.3% YoY
|
1.92
1.88 – 1.94
+7.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-08 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-07 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-06 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-05 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-04 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-30 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-29 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-28 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-27 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-24 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Amundi SDAX UCITS ETF Dist C005.DE | 1.29% | 2.31M | 0.70% |
| 2 | Amundi F.A.Z. 100 UCITS ETF Dist C006.DE | 0.15% | 169.7K | 0.15% |
| 3 | Vanguard Germany All Cap UCITS ETF (EUR) Distributing VGER.DE | 0.03% | 92.2K | 0.07% |
| 4 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.02% | 2.33M | 0.06% |
| 5 | Vanguard FTSE Europe Shares ETF VEQ.AX | 0.00% | 18.1K | 0.35% |
| 6 | Vanguard FTSE Europe ETF VGK | 0.00% | 1.55M | 0.06% |
| 7 | Vanguard FTSE Developed Europe All Cap Index ETF VE.TO | 0.00% | 17.0K | 0.23% |
| 8 | Dimensional - International Small Cap ETF DFIS | 0.00% | 138.4K | 0.39% |
| 9 | Vanguard FTSE Developed All Cap ex North America Index ETF (CAD-hedged) VI.TO | 0.00% | 14.1K | 0.22% |
| 10 | Vanguard FTSE Developed All Cap ex North America Index ETF VIU.TO | 0.00% | 162.6K | 0.23% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Franciscus Vrancken Peeters | Chief Executive Officer & Chairman of the Management Board | 2M | male |
| Carolyn Honour | Chief Commercial Officer & Member of the Management Board | 1M | female |
| Harshavardhan Jegadeesan | Chief Publishing Officer & Member of the Management Board | 1M | — |
| Alexandra Dambeck | CFO & Deputy Chair of Management Board | 1M | female |
| Marc Spenle | Chief Operating Officer & Member of the Management Board | 1M | male |
| Rachel Jacobs | Group General Counsel & Member of the Management Board | 855.0K | female |
| Tom Waldron | Head of Investor Relations | — | male |
| Maria Castresana | Chief People Officer | — | female |
| Matthias Wissel | Chief Information Officer | — | male |
| Ritu Dhand | Chief Scientific Officer | — | female |
| Steven C. Inchcoombe | President of Research | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for SPG.F
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
